TOT BIOPHARM INTERNA

1875

Delayed Hong Kong Stock Exchange - 04:08:49 2023-06-05 am EDT
2.400 HKD	+1.69%

Turn to zoom

Prev.	2.40000000
Open	2.36000000
High	2.40000000
Low	2.30000000
Volume	59 600

05/12	TOT BIOPHARM's Q1 Loss Widens Despite Higher Revenue
03/23	TOT BIOPHARM International Company Limited Reports Earnings Results for the...
03/20	TOT Biopharm Terminates Phase 3 Trial of Breast Cancer Drug; Shares Fall 5%
03/17	TOT BIOPHARM International Company Limited Announces Termination of Phase...

	Short Term	Mid-Term	Long Term
Trend	Neutral	Bullish	Neutral
Resistance	2,85	2,85	3,18
Spread/Res.	-16%	-16%	-25%
Spread/Supp.	3,9%	3,9%	35%
Support	2,31	2,31	1,78

Sales 2022	442 M 62,4 M 62,4 M
Net income 2022	-49,9 M -7,05 M -7,05 M
Net cash 2022	172 M 24,2 M 24,2 M
P/E ratio 2022	-27,1x
Yield 2022	-

Capitalization	1 648 M 233 M 233 M
EV / Sales 2021	28,7x
EV / Sales 2022	3,32x
Nbr of Employees	431
Free-Float	56,5%

TOT BIOPHARM International Company Limited is a company mainly engaged in the development and commercialization of oncology drugs and therapies. The Company has a portfolio of oncology drug candidates, which include monoclonal antibodies (mAbs), antibody drug conjugates (ADCs), oncolytic virus...

Sector :

Bio Therapeutic Drugs

Calendar :

2023-08-11 Earnings Release